Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
- PMID: 32100488
- PMCID: PMC7044007
- DOI: 10.3802/jgo.2020.31.e43
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment in
-
In reply: the evaluation of IgG titers' stability from blood samples is necessary.J Gynecol Oncol. 2020 Mar;31(2):e44. doi: 10.3802/jgo.2020.31.e44. J Gynecol Oncol. 2020. PMID: 32100489 Free PMC article. No abstract available.
Comment on
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.
Similar articles
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.
-
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493. BMJ. 2010. PMID: 20647284 Free PMC article. Clinical Trial.
-
Therapeutic HPV vaccine for cervical intraepithelial neoplasia.Lancet Oncol. 2019 May;20(5):e250. doi: 10.1016/S1470-2045(19)30224-4. Epub 2019 Apr 12. Lancet Oncol. 2019. PMID: 30987938 No abstract available.
-
Cervical cancer, human papillomavirus and vaccines.Clin Oncol (R Coll Radiol). 1993;5(6):386-90. doi: 10.1016/s0936-6555(05)80093-7. Clin Oncol (R Coll Radiol). 1993. PMID: 8305362 Review.
-
The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review.J Am Acad Dermatol. 2020 Jan;82(1):202-212. doi: 10.1016/j.jaad.2019.04.067. Epub 2019 May 11. J Am Acad Dermatol. 2020. PMID: 31085272